Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. (Q39075663)
Jump to navigation
Jump to search
scientific article published on 19 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. |
scientific article published on 19 October 2013 |
Statements
1 reference
Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. (English)
1 reference
Jiaxin Tan
1 reference
Yu You
1 reference
Tubin Xu
1 reference
Peng Yu
1 reference
Dingguo Wu
1 reference
Hao Deng
1 reference
Yujun Zhang
1 reference
Ping Bie
1 reference
19 October 2013
1 reference
1 reference
Identifiers
1 reference